GENE ONLINE|News &
Opinion
Blog

Ranking & Reports
Ranking & Reports Patent
Analysis of the Patent Industry for Treating Erectile Dysfunction (ED)
2023-06-08
Ranking & Reports Generic Drug
Investigate the Current Status of Rivaroxaban Generic Drug Application in China
2023-03-01
Ranking & Reports Gene Therapy
Patent Landscape Analysis of Gene Therapy
2023-02-08
Go Prime Gene Therapy
Will Breakthrough Therapy Lead the Way? An Overview of the Approved Gene and Cell Therapies for 2022
2023-01-13
Ranking & Reports Animal
Patent Landscape Analysis of Canine Vaccines
2023-01-04
Special FDA Approval
GeneOnline’s Pick: Top 10 New FDA-approved Drugs in 2022
2022-12-30
Special biopharma
GeneOnline’s Pick: Top 10 M&A Deals in 2022
2022-12-28
Special Healthcare Industry
GeneOnline’s Pick: Top 10 Industry News Stories in 2022
2022-12-26
Special Biologics
A Force To Be Reckoned With – BioBetter Biologics
2022-12-14
Ranking & Reports Synthetic Biologics
2026: The Promise of Synthetic Biology
2022-08-11
Special South Korea
Korean Companies Occupying South Korea’s Diverse Biotech Landscape
2022-08-03
Special KoreaBio
South Korea’s Biotech Industry：Trends, Landscape, and Clusters Overview
2022-08-01
Ranking & Reports FDA Approval
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
Special 2022 psychedelics
Cure or Poison? New Ventures Go IPO Continuously As “Psychedelics” Enter the Mental Health Market
2022-03-09
Ranking & Reports FDA Approved
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
1 2 3
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
READ MORE
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2023 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top